ReForm Biologics and KBI Biopharma have entered a strategic partnership to make improved biopharmaceutical formulations.    Through this collaboration, KBI and ReForm will help customers extend product lifecycles, enable improved dosing for patients, and enhance manufacturing efficiencies. As part of the strategic partnership, KBI has made an equity investment in ReForm Biologics.   KBI is a leading biopharmaceutical contract services company providing fully integrated drug devel...